Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Advanced Neuromodulation Systems, Inc. HARTFORD, Conn., March 1 /PRNewswire/ -- The law firm of Schatz & Nobel, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Eastern District of Texas on behalf of all persons who purchased the publicly traded securities of Advanced Neuromodulation Systems, Inc. (NasdaqNM: ANSI) between April 24, 2003 and February 16, 2005 (the "Class Period"). Advanced Neuromodulation Systems, Inc. ("the Company"), designs, develops, manufactures and markets implantable neuromodulation devices for people suffering from chronic pain. The Complaint alleges that the Company violated federal securities laws by issuing false or misleading public statements. Specifically, the Complaint alleges that during the Class Period the Company was engaged in an improper and unethical marketing plan whereby it would pay certain physicians for implanting the Company's products in patients. On February 17, 2005, the Company disclosed that it had received a subpoena from the Inspector General, Department of Health and Human Services, "requesting documents related to the Company's sales and marketing, reimbursement, Medicare and Medicaid billing, and certain other business practices." On this news, the Company's stock fell from a close of $37.60 per share on February 16, 2005, to close at $29.37 on February 17, 2005, on heavy trading volume. If you are a member of the class, you may, no later than May 2, 2005, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a class member that acts on behalf of other class members in directing the litigation. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions which could affect the overall recovery for class members, including decisions concerning settlement. The securities laws require the Court to consider the class member(s) with the largest financial interest as presumptively the most adequate lead plaintiff(s). For more information about the case, its claims, and your rights, please contact Schatz & Nobel toll-free at (800) 797-5499, or by e-mail at . To view a copy of the Complaint initiating the class action, which was not filed by Schatz & Nobel, or for more information about this case, class action cases in general, or Schatz & Nobel, please visit our website: http://www.snlaw.net/. CONTACT: Wayne T. Boulton or Nancy Kulesa Tel.: (800) 797-5499 Website: http://www.snlaw.net/ e-mail: DATASOURCE: Schatz & Nobel, P.C. CONTACT: Wayne T. Boulton or Nancy Kulesa, +1-800-797-5499, , both of Schatz & Nobel Web site: http://www.snlaw.net/

Copyright